Vanda

Washington, May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (NASDAQ:) Vanda (Nasdaq: VNDA) announced today that the company will participate in the Jefferies 2024 Global Healthcare Conference in... New York City on Thursday, June…

Habababa Vanda Pharmaceuticals (Nasdaq: VNDA) gained after three straight sessions of declines on Friday after it announced that the U.S. Food and Drug Administration had granted orphan drug designation for its experimental treatment…